Literature DB >> 17486048

Autoimmune liver disease: overlap and outliers.

Mary K Washington1.   

Abstract

The three main categories of autoimmune liver disease are autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC); all are well-defined entities with diagnosis based upon a constellation of clinical, serologic, and liver pathology findings. Although these diseases are considered autoimmune in nature, the etiology and possible environmental triggers of each remain obscure. The characteristic morphologic patterns of injury are a chronic hepatitis pattern of injury with prominent plasma cells in AIH, destruction of small intrahepatic bile ducts and canals of Hering in PBC, and periductal fibrosis and inflammation involving larger bile ducts with variable small duct damage in PSC. Serological findings include the presence of antimitochondrial antibodies in PBC, antinuclear, anti-smooth muscle, and anti-LKM antibodies in AIH, and pANCA in PSC. Although most cases of autoimmune liver disease fit readily into one of these three categories, overlap syndromes (primarily of AIH with PBC or PSC) may comprise up to 10% of cases, and variant syndromes such as antimitochondrial antibody-negative PBC also occur. Sequential syndromes with transition from one form of autoimmune liver disease to another are rare.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486048     DOI: 10.1038/modpathol.3800684

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

2.  Autoimmune cholangiopathy and high-output heart failure in a patient with graves disease.

Authors:  Deepak Venkat; Dylan Wirtz; Tushar Patel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

3.  Chronically inflamed livers up-regulate expression of inhibitory B7 family members.

Authors:  Rachel Kassel; Michael W Cruise; Julia C Iezzoni; Nicholas A Taylor; Timothy L Pruett; Young S Hahn
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

4.  Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.

Authors:  D M Foureau; T L Walling; V Maddukuri; W Anderson; K Culbreath; D E Kleiner; W A Ahrens; C Jacobs; P B Watkins; R J Fontana; N Chalasani; J Talwalkar; W M Lee; A Stolz; J Serrano; H L Bonkovsky
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

5.  Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.

Authors:  Emily Corse; Rachel A Gottschalk; Joon Seok Park; Manuel A Sepulveda; P'ng Loke; Timothy J Sullivan; Linda K Johnson; James P Allison
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

6.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

7.  Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.

Authors:  Florian P Reiter; Ralf Wimmer; Lena Wottke; Renate Artmann; Jutta M Nagel; Manuel O Carranza; Doris Mayr; Christian Rust; Peter Fickert; Michael Trauner; Alexander L Gerbes; Simon Hohenester; Gerald U Denk
Journal:  World J Hepatol       Date:  2016-03-18

Review 8.  PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma.

Authors:  Colleen S Curran; Elad Sharon
Journal:  Semin Oncol       Date:  2018-01-06       Impact factor: 4.929

9.  Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis.

Authors:  Shan Li; Xiamei Huang; Huizhi Zhong; Zhiping Chen; Qiliu Peng; Yan Deng; Xue Qin
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.